Common pathological mechanisms in mouse models for muscular dystrophies FASEB J. Turk et al.
10.1096/fj.05-4678fje
Supplemental Data
Files in this Data Supplement:
Supplemental Figure 1
-
(SupplementaryFigure1.ppt; 34 KB) Evaluation of Spp1 and S100a9 expression levels in the different animal models by quantitative PCR
Supplemental Table 2
-
Supplementary Table 2: (SupplementaryTable2.xls; 782 KB) List of genes differentially expressed between the 11 animal models evaluated, including averaged normalized expression levels and p-values
Supplemental Table 3
-
(SupplementaryTable3.xls; 195 KB) List of genes differentially expressed between severely affected animal models (group I) and mildly or non-affected animal models (group II), including p-values and fold-changes
Supplemental Table 4
-
(SupplementaryTable4.xls; 74 KB) List of genes in the different significantly overrepresented GO categories from Figure 4.
Supplemental Table 5
-
(SupplementaryTable5.xls; 20 KB) List of genes differentially expressed between sarcoglycan-deficient and dystrophin-deficient animal models, including p-values and fold-changes
-
(SupplementaryTable6.xls; 76 KB) List of genes differentially expressed between dysferlin-deficient and wild-type animals, including p-values and fold-changes